TV L250 Pill: yellow, oval
The pill with imprint TV L250 (Yellow, Oval, 0mm) has been identified as Lapatinib Ditosylate 250 mg and is used for Breast Cancer, and Breast Cancer, Metastatic. It belongs to the drug classes EGFR inhibitors, HER2 inhibitors and is not a controlled substance.
Images for TV L250
Lapatinib Ditosylate
- Imprint
- TV L250
- Strength
- 250 mg
- Color
- Yellow
- Shape
- Oval (film-coated)
- Availability
- Prescription only
- Drug Class
- EGFR inhibitors, HER2 inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
- 00480-3237
See also:
More about lapatinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.